gabexate has been researched along with Acantholysis in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Acantholysis: Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S | 1 |
| Ogawa, H | 1 |
| Naito, K | 1 |
2 other studies available for gabexate and Acantholysis
| Article | Year |
|---|---|
Effects of steroid, retinoid, and protease inhibitors on the formation of acantholysis induced in organ culture of skins from patients with benign familial chronic pemphigus.
Topics: Acantholysis; Adult; Betamethasone; Diterpenes; Esters; Female; Gabexate; Guanidines; Humans; Male; | 1991 |
[The identification of inhibitors of acantholysis of pemphigus vulgaris].
Topics: Acantholysis; Animals; Fibrinolysin; Gabexate; Guanidines; Humans; Mice; Mice, Inbred BALB C; Pemphi | 1987 |